Advanced High‐Entropy Biomaterials (HEBs)
Small · 2026-06 · 22 (32)
DOI: 10.1002/smll.73820 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small, online erschienen am 19.05.2026. Verfasst von Xiaowen Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Biocompatible Materials, Entropy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 169 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Program, Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
High‐entropy materials (HEMs), characterized by their unique multi‐principal elemental compositions (typically five or more elements in near‐equiatomic mixing), represent a paradigm‐shifting class of substances. This compositional hallmark leads to four core effects, including high‐entropy, severe lattice distortion, sluggish diffusion, and the “cocktail effect”. These effects collectively endow HEMs with exceptional and tunable properties, such as mechanical strength, catalytic activities, and multi‐functionality, which are highly attractive for biomedical applications. The recent exploitation of HEMs in biomedicine has been rapidly expanding, but a comprehensive review that summarizes and highlights these advances and their implications is still lacking. This review commences with a detailed discussion on the fundamental characteristics of high‐entropy biomaterials (HEBs), deciphering the interplay between their core effects and key physicochemical properties. We then provide a comprehensive overview of their cutting‐edge biomedical applications, spanning bone tissue engineering, vascular stents, tumor therapy, anti‐inflammatory treatment, antimicrobial interventions, and biosensing. Finally, we discuss the future challenges and opportunities, emphasizing the importance of biosafety evaluation and the promising integration of computational simulations and artificial intelligence to accelerate the rational design of next‐generation HEBs for facilitating clinical translations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai, China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.
- Department of Radiology, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China.
ORCID-Profile: Yu Chen
Förderung
- National Natural Science Foundation of China
- Shanghai Science and Technology Program
- Postdoctoral Fellowship Program of CPSF
- Discipline Construction of Pudong New Area Health Commission
- Shanghai Pudong New District Health Committee Health Industry Special Project
- Shanghai Pudong New Area Health Commission
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, X., Zhou, S., Zhu, J., Huang, H., Huang, B., & Chen, Y. (2026). Advanced High‐Entropy Biomaterials (HEBs). Small, 22(32). https://doi.org/10.1002/smll.73820
Vancouver
Wang X, Zhou S, Zhu J, Huang H, Huang B, Chen Y. Advanced High‐Entropy Biomaterials (HEBs). Small. 2026;22(32). doi:10.1002/smll.73820
BibTeX
@article{Wang2026,
author = {Wang, Xiaowen and Zhou, Siyu and Zhu, Jiangling and Huang, Hui and Huang, Bingcang and Chen, Yu},
title = {Advanced High‐Entropy Biomaterials (HEBs)},
journal = {Small},
year = {2026},
volume = {22},
number = {32},
doi = {10.1002/smll.73820}
}
EUVIMED